Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)
First Week of January 2015 Options Trading For Affymetrix (AFFX)

First Week of January 2015 Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options become available this week, for the January 2015 expiration.

Toshiba Corporation Selects Affymetrix Axiom Platform For Its Newly Launched Genotyping Service In Japan

Toshiba Corporation Selects Affymetrix Axiom Platform For Its Newly Launched Genotyping Service In Japan

Affymetrix (NASDAQ: AFFX) announces its Axiom® Genotyping Solution platform has been selected by Toshiba Corporation's (TYO: 6502) Healthcare Company as the platform for its newly launched genotyping...

'Mad Money' Lightning Round: A Group to Avoid

'Mad Money' Lightning Round: A Group to Avoid

Cramer says he's not going against Affymetrix, and doesn't want to get back into the sand game.

Jim Cramer's 'Mad Money' Recap: Market 'Losers' Back in the Game

Jim Cramer's 'Mad Money' Recap: Market 'Losers' Back in the Game

Some stocks written off by this market are looking better than ever, Cramer says.

Affymetrix Announces Webcast Of Investor Day 2014 On Monday November 17, 2014

Affymetrix Announces Webcast Of Investor Day 2014 On Monday November 17, 2014

Affymetrix, Inc. (NASDAQ: AFFX) today announced that the company will host a live webcast in conjunction with its Investor Day on Monday, November 17, 2014 at 11:30 a.

Affymetrix Launches Solution To Enable Cancer Researchers To Rapidly Map The Functional Impact Of DNA Alterations On Gene Expression Profiles To Identify Potential Cancer Driver Events

Affymetrix Launches Solution To Enable Cancer Researchers To Rapidly Map The Functional Impact Of DNA Alterations On Gene Expression Profiles To Identify Potential Cancer Driver Events

Affymetrix (NASDAQ:AFFX) announced today the launch of Concurrent Molecular Analysis Profiling (CoMAP™) capability, which enables cancer researchers to gain rapid insight into the functional impact of ...

Affymetrix (AFFX) Is Today's Strong On High Volume Stock

Affymetrix (AFFX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Affymetrix (AFFX) as a strong on high relative volume candidate

Affymetrix Reports Third Quarter 2014 Operating Results

Affymetrix Reports Third Quarter 2014 Operating Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the third quarter of 2014.

Affymetrix Exclusively Licenses Technology From Peptide Groove LLP For HLA Typing From Genotyping Data

Affymetrix Exclusively Licenses Technology From Peptide Groove LLP For HLA Typing From Genotyping Data

Affymetrix (NASDAQ:AFFX) announced today that it has exclusively licensed technology from Peptide Groove LLP that enables HLA typing of human samples from genotyping data generated from a variety of assays ...

Affymetrix Enters Oversold Territory (AFFX)

Affymetrix Enters Oversold Territory (AFFX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Affymetrix To Report Third Quarter 2014 Operating Results On Thursday October 30, 2014

Affymetrix To Report Third Quarter 2014 Operating Results On Thursday October 30, 2014

Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the third quarter of 2014 after market close on Thursday October 30, 2014.

Interesting AFFX Put And Call Options For May 2015

Interesting AFFX Put And Call Options For May 2015

Investors in Affymetrix, Inc. saw new options become available this week, for the May 2015 expiration.

Affymetrix Reports Second Quarter 2014 Operating Results

Affymetrix Reports Second Quarter 2014 Operating Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2014.

First Week of September 20th Options Trading For Affymetrix (AFFX)

First Week of September 20th Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options become available this week, for the September 20th expiration.

Short Interest Drops 14% For AFFX

Short Interest Drops 14% For AFFX

The most recent short interest data has been released by the NASDAQ for the 06/30/2014 settlement date, which shows a 1,381,355 share decrease in total short interest for Affymetrix, Inc. , to 8,433,177, a decrease of 14.07% since 06/13/2014.

Affymetrix To Report Second Quarter 2014 Operating Results On Thursday July 31, 2014

Affymetrix To Report Second Quarter 2014 Operating Results On Thursday July 31, 2014

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will report operating results for the second quarter of 2014 after market close on Thursday July 31, 2014.

First Week Of February 2015 Options Trading For Affymetrix (AFFX)

First Week Of February 2015 Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options begin trading this week, for the February 2015 expiration.

Affymetrix Announces Recipients Of Its 2014 Tumor Profiling Grant Award To Support Translational Cancer Research

Affymetrix Announces Recipients Of Its 2014 Tumor Profiling Grant Award To Support Translational Cancer Research

Affymetrix (Nasdaq:AFFX) announces the three recipients who have been awarded its 2014 Affymetrix Tumor Profiling Grant.

Affymetrix And BioDiscovery Launch A Tailored Copy Number Analysis Software Solution For Cancer Research

Affymetrix And BioDiscovery Launch A Tailored Copy Number Analysis Software Solution For Cancer Research

Affymetrix (Nasdaq: AFFX) and BioDiscovery, Inc. today announced the launch of a new analysis software, Nexus Copy Number for Affymetrix, which is specifically for data generated by Affymetrix’ genetic analysis ...

First Week of July 19th Options Trading For Affymetrix (AFFX)

First Week of July 19th Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options begin trading this week, for the July 19th expiration.

Affymetrix And Leica Biosystems Announce The Launch Of Fully Automated RNA In Situ Hybridization Assays

Affymetrix And Leica Biosystems Announce The Launch Of Fully Automated RNA In Situ Hybridization Assays

Affymetrix, Inc. (NASDAQ:AFFX) and Leica Biosystems announce the launch of Affymetrix’ fully automated RNA in situ hybridization assays ViewRNATM eZ Assays on the Leica BOND RX staining platform.

Affymetrix Reports First Quarter 2014 Operating Results

Affymetrix Reports First Quarter 2014 Operating Results

Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the first quarter of 2014.

Interesting AFFX Call Options For June 21st

Interesting AFFX Call Options For June 21st

Investors in Affymetrix, Inc. saw new options become available this week, for the June 21st expiration.

Affymetrix To Report First Quarter 2014 Operating Results On Thursday May 1st, 2014

Affymetrix To Report First Quarter 2014 Operating Results On Thursday May 1st, 2014

Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the first quarter of 2014 after market close on Thursday May 1, 2014.

Interesting AFFX Put And Call Options For November 22nd

Interesting AFFX Put And Call Options For November 22nd

Investors in Affymetrix, Inc. saw new options begin trading this week, for the November 22nd expiration.

First Week of April 19th Options Trading For Affymetrix (AFFX)

First Week of April 19th Options Trading For Affymetrix (AFFX)

Investors in Affymetrix, Inc. saw new options begin trading this week, for the April 19th expiration.

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Oversold Conditions For Affymetrix (AFFX)

Oversold Conditions For Affymetrix (AFFX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Affymetrix Reports Fourth Quarter And Fiscal Year 2013 Results

Affymetrix Reports Fourth Quarter And Fiscal Year 2013 Results

Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the three and twelve months ended December 31, 2013.